Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |